GO:0004980 melanocyte-stimulating hormone receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004980 describes the molecular function of combining with melanocyte-stimulating hormone (MSH) to initiate a change in cell activity.
• The receptor is a G-protein-coupled receptor that signals primarily through adenylate cyclase and cAMP.
• Agouti protein acts as a natural antagonist of the MSH receptor, blocking its activity.
• MSH receptor expression on normal human melanocytes is modulated by UVB, interleukin-1alpha, interleukin-1beta, endothelin-1 and tumour necrosis factor-alpha.
• The human MSH receptor has evolved to become super-sensitive to melanocortin peptides, enabling responses at low hormone concentrations.
• Alpha-MSH protects retinal pigment epithelium cells from oxidative stress via melanocortin 1 receptor-Akt-mTOR signaling.
Description
Melanocyte-stimulating hormone receptor activity (GO:0004980) is a molecular function defined as combining with melanocyte-stimulating hormone to initiate a change in cell activity. This activity is mediated by the melanocortin 1 receptor (MC1R), a G-protein-coupled receptor expressed on melanocytes and other cell types. The receptor binds alpha-melanocyte-stimulating hormone (alpha-MSH) and related melanocortin peptides, triggering intracellular signaling cascades that regulate pigmentation, cell survival, and stress responses. Researchers study this activity to understand pigmentary disorders, melanoma biology, and neuroendocrine-immune interactions. The receptor's ability to respond to very low concentrations of MSH, termed super-sensitivity, has been demonstrated in the human receptor. Discontinuous binding of MSH to synchronized mouse melanoma cells during the cell cycle further highlights the dynamic regulation of this receptor.
melanocyte-stimulating hormone receptor activity At A Glance
| GO ID | GO:0004980 |
|---|---|
| GO term | melanocyte-stimulating hormone receptor activity |
| Ontology | molecular_function |
| Synonym | melanocyte stimulating hormone receptor activity; melanophore-stimulating hormone receptor activity; MSHR activity; MSH receptor activity |
| Major function | Binding melanocyte-stimulating hormone to initiate intracellular signaling |
| Major receptor | Melanocortin 1 receptor (MC1R) |
| Signaling pathway | G-protein-coupled receptor; adenylate cyclase/cAMP |
| Natural antagonist | Agouti protein |
| Regulation | Modulated by UVB, IL-1alpha, IL-1beta, endothelin-1, TNF-alpha |
What Is GO:0004980?
In simple terms, GO:0004980 is the function of a receptor protein that binds melanocyte-stimulating hormone and, by doing so, triggers a change inside the cell. This activity is typically measured by hormone binding and subsequent intracellular signaling, such as activation of adenylate cyclase. The official definition is: Combining with melanocyte-stimulating hormone to initiate a change in cell activity.
Why Is melanocyte-stimulating hormone receptor activity Important in Cell Biology?
Melanocyte-stimulating hormone receptor activity is central to skin pigmentation, photoprotection, and melanocyte survival. It is also implicated in melanoma progression, oxidative stress responses in the retinal pigment epithelium, and neuroendocrine signaling. Understanding this activity helps researchers develop therapies for pigmentation disorders, melanoma, and degenerative conditions linked to oxidative stress.
• Regulates melanin synthesis and skin pigmentation.
• Mediates photoprotection by stimulating melanocyte proliferation and melanogenesis.
• Modulates oxidative stress responses in retinal pigment epithelium via Akt-mTOR signaling.
• Is antagonized by Agouti protein, linking it to coat color regulation and energy homeostasis.
• Shows cell-cycle-dependent binding of MSH, affecting responsiveness.
• Expression is modulated by UVB and inflammatory cytokines, linking skin inflammation to pigmentation.
• The human receptor is super-sensitive to melanocortin peptides, enabling responses at low hormone levels.
• ACTH/MSH-like peptides modulate adenylate cyclase in brain slices, suggesting roles in the central nervous system.
• Implicated in melanoma biology and potential targeted therapies.
• Provides a model for studying G-protein-coupled receptor signaling and desensitization.
What Happens During melanocyte-stimulating hormone receptor activity?
Hormone Binding
In simple terms: The hormone attaches to the receptor on the cell surface.
Melanocyte-stimulating hormone (MSH) binds to the extracellular domain of the melanocortin 1 receptor (MC1R). This binding is specific and saturable, and in synchronized mouse melanoma cells, binding is discontinuous during the cell cycle, indicating that receptor availability or affinity changes with cell cycle phase. The human receptor exhibits super-sensitivity to melanocortin peptides, allowing activation at low physiological concentrations.
Receptor Activation and G-Protein Coupling
In simple terms: The receptor changes shape and activates a G-protein inside the cell.
Upon MSH binding, the receptor undergoes a conformational change that promotes coupling to the stimulatory G-protein Gs. This leads to the activation of adenylate cyclase, which converts ATP to cyclic AMP (cAMP). This mechanism has been demonstrated in rat brain slices, where ACTH/MSH-like peptides modulate adenylate cyclase activity via an ACTH/MSH receptor-coupled mechanism.
Downstream Signaling
In simple terms: The signal spreads inside the cell, turning on various responses.
Elevated cAMP activates protein kinase A (PKA) and other effectors, leading to changes in gene expression, melanin synthesis, and cell survival. In retinal pigment epithelium cells, alpha-MSH protects against oxidative stress through activation of melanocortin 1 receptor-Akt-mTOR signaling. This pathway highlights the receptor's role beyond pigmentation, linking it to cell survival and stress resistance.
Antagonism by Agouti Protein
In simple terms: A protein called Agouti can block the receptor.
Agouti protein acts as a natural antagonist of the melanocyte-stimulating hormone receptor, preventing MSH binding and downstream signaling. This antagonism is critical for regulating coat color in mammals and may influence energy homeostasis. The balance between MSH and Agouti determines the level of receptor activity.
Key Genes Involved in GO:0004980 melanocyte-stimulating hormone receptor activity
The following genes and proteins are directly involved in melanocyte-stimulating hormone receptor activity and its signaling pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MC1R | Melanocortin 1 receptor; binds MSH and activates Gs/adenylate cyclase | Central to pigmentation, melanoma, and oxidative stress responses |
| POMC | Precursor of alpha-MSH and ACTH | Provides the endogenous ligands for the receptor |
| ASIP | Agouti signaling protein; natural antagonist of MC1R | Regulates receptor activity and coat color |
| GNAS | Stimulatory G-protein alpha subunit; couples MC1R to adenylate cyclase | Mediates cAMP signaling downstream of receptor |
| ADCY | Adenylate cyclase; produces cAMP | Key effector of receptor activation |
| PRKACA | Protein kinase A catalytic subunit; mediates cAMP effects | Phosphorylates downstream targets |
| AKT1 | Serine/threonine kinase; involved in survival signaling | Mediates protective effects of alpha-MSH in RPE cells |
| MTOR | Kinase; regulates cell growth and survival | Part of the MC1R-Akt-mTOR pathway |
| TYR | Tyrosinase; rate-limiting enzyme in melanin synthesis | Upregulated by MSH signaling |
| MITF | Microphthalmia-associated transcription factor; master regulator of melanocyte genes | Downstream target of MSH signaling |
| IL1A | Interleukin-1 alpha; modulates MSH receptor expression | Links inflammation to pigmentation |
| IL1B | Interleukin-1 beta; modulates MSH receptor expression | Links inflammation to pigmentation |
| EDN1 | Endothelin-1; modulates MSH receptor expression | Regulates melanocyte responses to UV |
| TNF | Tumor necrosis factor-alpha; modulates MSH receptor expression | Links inflammation to pigmentation |
| MC3R | Melanocortin 3 receptor; related family member | May share ligands and signaling mechanisms |
| MC4R | Melanocortin 4 receptor; related family member | May share ligands and signaling mechanisms |
| MC5R | Melanocortin 5 receptor; related family member | May share ligands and signaling mechanisms |
How Is melanocyte-stimulating hormone receptor activity Regulated?
Melanocyte-stimulating hormone receptor activity is regulated at multiple levels. Receptor expression on normal human melanocytes is modulated by ultraviolet B (UVB) radiation, interleukin-1alpha, interleukin-1beta, endothelin-1, and tumour necrosis factor-alpha. This indicates that inflammatory mediators and UV exposure can alter receptor levels, thereby affecting cellular responsiveness to MSH. Additionally, the receptor's binding capacity varies with the cell cycle, as shown by discontinuous binding of MSH to synchronized mouse melanoma cells. The human receptor has evolved to become super-sensitive to melanocortin peptides, allowing activation at low hormone concentrations. Antagonism by Agouti protein provides another layer of regulation, blocking receptor activity. Downstream, the MC1R-Akt-mTOR pathway mediates protective effects against oxidative stress.
melanocyte-stimulating hormone receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MC1R | Melanoma, pigmentation disorders | Knockout or point-mutation in melanoma cell lines |
| POMC | Obesity, adrenal insufficiency | Knockout mouse models |
| ASIP | Obesity, pigmentation variation | Overexpression in melanocytes |
| AKT1 | Oxidative stress-related retinal degeneration | Knock-in of constitutively active Akt1 in RPE cells |
| MTOR | Retinal degeneration, cancer | Knockout or point-mutation in RPE cells |
Melanoma and Pigmentary Disorders
Melanocyte-stimulating hormone receptor activity is critical for melanocyte function, and its dysregulation is implicated in melanoma and pigmentary disorders. The receptor's role in stimulating melanin synthesis and melanocyte proliferation is well established. UV light and MSH receptors are linked to melanoma development, and receptor expression is modulated by UVB and inflammatory cytokines. Targeting this receptor pathway may offer therapeutic strategies for melanoma.
Oxidative Stress and Retinal Degeneration
Alpha-MSH protects retinal pigment epithelium cells from oxidative stress through activation of melanocortin 1 receptor-Akt-mTOR signaling. This suggests that melanocyte-stimulating hormone receptor activity may be relevant to retinal degenerative diseases and conditions involving oxidative stress. Enhancing this pathway could be protective in such contexts.
Neuroendocrine and Metabolic Regulation
ACTH/MSH-like peptides modulate adenylate cyclase activity in rat brain slices, indicating that MSH receptor activity may play a role in central nervous system functions. Additionally, Agouti protein antagonism of the MSH receptor links this activity to energy homeostasis and coat color regulation. These findings suggest broader physiological roles beyond pigmentation.
From melanocyte-stimulating hormone receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does MC1R mediate MSH-induced pigmentation? | MC1R knockout melanocytes |
| How does a specific MC1R variant affect signaling? | Point-mutation knock-in in melanoma cells |
| Can tagged MC1R be used to track receptor trafficking? | Knock-in of fluorescent tag at MC1R locus |
| Does overexpression of MC1R enhance oxidative stress resistance? | Overexpression of MC1R in RPE cells |
| What genes are essential for MSH receptor signaling? | CRISPR library screening in melanocytes |
| How does Agouti antagonism affect downstream transcription? | ASIP overexpression in melanocytes |
How to Study the melanocyte-stimulating hormone receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding | Receptor affinity and density | Characterizing MSH binding to MC1R |
| cAMP assay | Adenylate cyclase activity | Measuring receptor activation |
| RNA-seq | Transcriptional changes | Identifying downstream targets of MSH signaling |
| Western blot | Protein expression and phosphorylation | Assessing Akt/mTOR activation |
| Immunofluorescence | Receptor localization | Visualizing MC1R trafficking |
| CRISPR knockout | Gene function | Testing essentiality of MC1R pathway genes |
| CRISPR activation | Gene overexpression | Screening for enhancers of MSH signaling |
Binding Assays
Radioligand binding assays using iodinated MSH can measure receptor affinity and density on melanocytes. Discontinuous binding during the cell cycle was demonstrated using synchronized mouse melanoma cells. These assays are essential for characterizing receptor-ligand interactions.
cAMP Measurement
Activation of adenylate cyclase and production of cAMP can be measured using radioimmunoassays or luminescent reporters. ACTH/MSH-like peptides modulate adenylate cyclase activity in rat brain slices, providing a functional readout of receptor activity.
Gene Expression Analysis
Quantitative RT-PCR and RNA-seq can assess expression of MC1R and downstream targets such as TYR and MITF. Modulation of MSH receptor expression by UVB and cytokines was demonstrated using such methods.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate MSH receptor activity or downstream signaling. This approach is powerful for discovering novel components of the pathway.
How CRISPR Can Be Used to Study GO:0004980 melanocyte-stimulating hormone receptor activity
Knockout
CRISPR knockout of MC1R or downstream signaling genes can abolish MSH receptor activity, providing a clean background to study receptor function. For example, MC1R knockout melanocytes fail to respond to MSH, confirming its essential role.
Point Mutation
Introducing specific point mutations in MC1R, such as those associated with red hair and melanoma risk, allows researchers to study how these variants affect receptor signaling and super-sensitivity. Point mutations can also be used to map functional domains.
Knock-in
Knock-in of tagged MC1R (e.g., GFP or HA) enables real-time tracking of receptor localization and trafficking. Knock-in of reporter genes under the control of MSH-responsive promoters can monitor pathway activity.
Overexpression
Overexpression of MC1R or its ligands can enhance MSH signaling, useful for studying protective effects against oxidative stress. Overexpression models can also reveal desensitization mechanisms.
How EDITGENE Supports melanocyte-stimulating hormone receptor activity Research
Researchers studying melanocyte-stimulating hormone receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor signaling, pigmentation, or disease. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for melanocyte-stimulating hormone receptor activity research.
Frequently Asked Questions About melanocyte-stimulating hormone receptor activity
What is melanocyte-stimulating hormone receptor activity?
It is the molecular function of binding melanocyte-stimulating hormone to initiate a change in cell activity, as defined by GO:0004980.
What genes are involved in melanocyte-stimulating hormone receptor activity?
Key genes include MC1R, POMC, ASIP, GNAS, and downstream effectors like AKT1 and MTOR.
How does the MSH receptor signal?
It couples to Gs, activates adenylate cyclase, and increases cAMP, leading to PKA activation and downstream effects.
What diseases are associated with MSH receptor activity?
Melanoma, pigmentary disorders, and oxidative stress-related retinal degeneration.
What is the role of Agouti protein in MSH receptor activity?
Agouti protein acts as a natural antagonist, blocking MSH binding and signaling.
How is MSH receptor expression regulated?
It is modulated by UVB, IL-1alpha, IL-1beta, endothelin-1, and TNF-alpha.
Why is the human MSH receptor considered super-sensitive?
It has evolved to respond to very low concentrations of melanocortin peptides.
Can CRISPR be used to study MSH receptor activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are valuable for dissecting receptor function.
What methods measure MSH receptor activity?
Radioligand binding, cAMP assays, RNA-seq, and Western blot are commonly used.
What cell types express MSH receptors?
Melanocytes, melanoma cells, retinal pigment epithelium, and some brain cells.
Conclusion
Melanocyte-stimulating hormone receptor activity (GO:0004980) is a fundamental molecular function that governs pigmentation, stress responses, and neuroendocrine signaling. Its central role in melanoma and oxidative stress-related diseases makes it a prime target for therapeutic development. Advances in CRISPR technology and screening methods continue to unravel the complexities of this receptor pathway, offering new opportunities for research and drug discovery.
References
- 1. Hadley ME et al.. 1981. Biological actions of melanocyte-stimulating hormone.. Ciba Found Symp 81:244-62 PMID: 6268380
- 2. Lu D et al.. 1994. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor.. Nature 371(6500):799-802 PMID: 7935841
- 3. Varga JM et al.. 1974. Regulation of melanocyte stimulating hormone action at the receptor level: discontinuous binding of hormone to synchronized mouse melanoma cells during the cell cycle.. Proc Natl Acad Sci U S A 71(5):1590-3 PMID: 4365570
- 4. Funasaka Y et al.. 1998. Modulation of melanocyte-stimulating hormone receptor expression on normal human melanocytes: evidence for a regulatory role of ultraviolet B, interleukin-1alpha, interleukin-1beta, endothelin-1 and tumour necrosis factor-alpha.. Br J Dermatol 139(2):216-24 PMID: 9767234
- 5. Cheng LB et al.. 2014. Alpha-melanocyte stimulating hormone protects retinal pigment epithelium cells from oxidative stress through activation of melanocortin 1 receptor-Akt-mTOR signaling.. Biochem Biophys Res Commun 443(2):447-52 PMID: 24316214
- 6. Mountjoy KG. 1994. The human melanocyte stimulating hormone receptor has evolved to become "super-sensitive" to melanocortin peptides.. Mol Cell Endocrinol 102(1-2):R7-11 PMID: 7926261
- 7. Florijn WJ et al.. 1993. Adrenocorticotropin/alpha-melanocyte-stimulating hormone (ACTH/MSH)-like peptides modulate adenylate cyclase activity in rat brain slices: evidence for an ACTH/MSH receptor-coupled mechanism.. J Neurochem 60(6):2204-11 PMID: 8388034
- 8. Chakraborty AK et al.. 1999. UV light and MSH receptors.. Ann N Y Acad Sci 885:100-16 PMID: 10816644
